Endonucleases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9650618
APP PUB NO 20160355798A1
SERIAL NO

15211843

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an endonuclease I or enzymatically active fragment thereof wherein said endonuclease I has the sequence of SEQ ID No. 4 or a sequence which is at least 70% identical thereto and wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a residue which is negatively charged as well as nucleic acid molecules encoding these enzymes and methods of removing contaminating polynucleotides from a sample using these enzyme.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOTEC PHARMACON ASA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Altermark, Bjørn Tromsø, NO 3 1
Havdalen, Linda Tromsø, NO 2 1
Helland, Ronny Tromsdalen, NO 2 1
Lanes, Olav Tromsø, NO 12 39
Leiros, Ingar Tromsø, NO 2 1
Lorentzen, Marit Krokelvdalen, NO 2 1
Solstad, Terese Kvaløysletta, NO 7 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00